SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________________ to _________________________ Commission File Number: 001-36790 Predictive Oncology Inc. (Exact name of registrant as specified in its charter) Delaware 33-100 ...

(Mark One) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Predictive Oncology Inc. (Exact name of registrant as specified in its charter) | Delaware | 33-1007393 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 2915 Commers Drive, Suite 900 | Eagan, Minnesota 55121 | (Address of principal executive offices) (Zip Code) 651-389-4800 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCH ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 001-36790 PREDICTIVE ONCOLOGY INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction (IRS Employer of incorporation o ...

Predictive Oncology Inc. (NASDAQ:POAI) Q2 2019 Results Earnings Conference Call August 19, 2019 5:30 PM ET Company Participants Scott Gordon - IR, CORE IR Carl Schwartz - President and CEO Bob Myers - CFO Gerald Vardzel - President of Helomics Amelia Warner - COO of Helomics Conference Call Participants Jason Kolbert - Dawson James Operator Good afternoon, and welcome to the Predictive Oncology Earnings Conference Call for the Second Quarter Ending June 30, 2019. All participants will be in a listen-only mo ...

Precision Therapeutics Inc. (AIPT) Q1 2019 Earnings Conference Call May 15, 2019 4:30 PM ET Company Participants Scott Gordon - Investor Relations, CORE IR Carl Schwartz - President and Chief Executive Officer Bob Myers - Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the Precision Therapeutics Earnings Conference Call for the First Quarter Ended March 31, 2019. All participants will be in a listen-only mode. [Operator Instructions] Participants of this call are ...

Precision Therapeutics Inc. (AIPT) Q4 2018 Earnings Conference Call April 1, 2019 4:30 PM ET Company Participants Scott Gordon - IR, CORE IR Dr. Carl Schwartz - President and CEO Bob Myers - CFO Jerry Vardzel - CEO, Helomics Corp Richard Gabriel - Board Member Conference Call Participants Operator Good afternoon and welcome to the Precision Therapeutics Earnings Conference Call for the year-ended December 31, 2018. All participants will be in a listen-only mode. [Operator Instructions]. Participants of this ...